BYDUREON PEN (exenatide synthetic) Astrazeneca ab Patent: 7,223,440 Expiration: Mar 3, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations …
Drug Patent Expirations for the Week of February 27, 2022 Read Post »
Annual Drug Patent Expirations for BEYAZ Beyaz is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are four patents…
The post New patent expiration for Bayer Hlthcare drug BEYAZ appeared first on D…
New patent expiration for Bayer Hlthcare drug BEYAZ Read Post »
Annual Drug Patent Expirations for SAFYRAL Safyral is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for Bayer Hlthcare drug SAFYRAL appeared fir…
New patent expiration for Bayer Hlthcare drug SAFYRAL Read Post »
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent expiration for Astrazeneca Ab drug BYDUREON BCIS…
New patent expiration for Astrazeneca Ab drug BYDUREON BCISE Read Post »
Annual Drug Patent Expirations for TEKTURNA+HCT Tekturna Hct is a drug marketed by Noden Pharma and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Noden Pharma drug TEKTURNA HCT appeared fir…
New patent expiration for Noden Pharma drug TEKTURNA HCT Read Post »
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have supplementary protec…
Which drugs have supplementary protection certificates in the most countries? Read Post »
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twenty-three patents…
The post New patent expiration for Astrazeneca Ab drug BYDUREON ap…
New patent expiration for Astrazeneca Ab drug BYDUREON Read Post »
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-two…
The post New patent expiration for Astrazeneca Ab drug BYDUREON PEN a…
New patent expiration for Astrazeneca Ab drug BYDUREON PEN Read Post »
This chart shows the patent expirations for tablet dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
The post Tablet dosed drug patent expirations by year appeared first on DrugPatentWatch …
Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. There are twenty-seven patents protecting this drug. This drug…
The post New patent for Amicus Therap drug GALAFOLD appeared first o…
Get new actionable insights and updates from BiotechBlog
